2025 · 4th Quarter (Oct 1 - Dec 31)

THE UNITED STATES PHARMACOPEIAL CONVENTION

Filed by THE UNITED STATES PHARMACOPEIAL CONVENTION.

Open official filing

Source-reported fields

Filing overview

Type: 4th Quarter - Report
Posted: Jan 20, 2026
Income: Not reported
Expenses: $100,000.00
Registrant: THE UNITED STATES PHARMACOPEIAL CONVENTION
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION
Filing UUID: dec73445-3522-4c2a-a97a-bad8b9e25e36
Termination date: Not reported

Expense method: B

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

H.R. 5304, S.2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; H.R. 4779 National Security, Department of State, and Related Programs Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.

Literal federal measure citations: H.R. 5304, S.2587, H.R. 4779

DEF · Defense

S. 2296 - National Defense Authorization Act for Fiscal Year 2026: Provisions regarding medicine supply chain.

Literal federal measure citations: S. 2296

HCR · Health Issues

S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages.

Literal federal measure citations: S. 1784, H.R. 4191

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.